- Home
- RLYB vs LEE Comparison
RLYB vs LEE Comparison
Compare RLYB & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLYB
- LEE
- Stock Information
- Founded
- RLYB 2018
- LEE 1890
- Country
- RLYB United States
- LEE United States
- Employees
- RLYB N/A
- LEE N/A
- Industry
- RLYB Biotechnology: Pharmaceutical Preparations
- LEE Newspapers/Magazines
- Sector
- RLYB Health Care
- LEE Consumer Discretionary
- Exchange
- RLYB Nasdaq
- LEE Nasdaq
- Market Cap
- RLYB 45.6M
- LEE 53.9M
- IPO Year
- RLYB 2021
- LEE N/A
- Fundamental
- Price
- RLYB $1.11
- LEE $15.30
- Analyst Decision
- RLYB Buy
- LEE
- Analyst Count
- RLYB 6
- LEE 0
- Target Price
- RLYB $8.30
- LEE N/A
- AVG Volume (30 Days)
- RLYB 50.8K
- LEE 58.3K
- Earning Date
- RLYB 11-07-2024
- LEE 12-05-2024
- Dividend Yield
- RLYB N/A
- LEE N/A
- EPS Growth
- RLYB N/A
- LEE N/A
- EPS
- RLYB N/A
- LEE N/A
- Revenue
- RLYB $299,000.00
- LEE $616,815,000.00
- Revenue This Year
- RLYB N/A
- LEE N/A
- Revenue Next Year
- RLYB N/A
- LEE N/A
- P/E Ratio
- RLYB N/A
- LEE N/A
- Revenue Growth
- RLYB N/A
- LEE N/A
- 52 Week Low
- RLYB $1.08
- LEE $7.56
- 52 Week High
- RLYB $4.60
- LEE $16.49
- Technical
- Relative Strength Index (RSI)
- RLYB 45.55
- LEE 76.49
- Support Level
- RLYB $1.08
- LEE $8.54
- Resistance Level
- RLYB $1.18
- LEE $16.49
- Average True Range (ATR)
- RLYB 0.04
- LEE 0.99
- MACD
- RLYB 0.00
- LEE 0.73
- Stochastic Oscillator
- RLYB 15.00
- LEE 81.13
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
About LEE Lee Enterprises Incorporated
Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high quality, trusted, intensely local news, information, advertising and marketing services. Its product portfolio includes digital subscription platforms, daily, weekly and monthly newspapers and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and its content and advertising is available in real time through the websites and mobile apps.